Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Summary of Weighted Average Assumptions used in the Black-Scholes-Merton Option-Pricing Model

The weighted average assumptions used in the Black-Scholes-Merton option-pricing model for the units granted during the years ended December 31, 2022 and 2021 Stock Options are provided in the following table:

	December 31, 2022	December 31, 2021
Valuation assumptions:
Expected dividend yield	—%	—%
Expected volatility	35.0% to 60.0%	35.00% to 40.20%
Risk-free interest rate	2.33% to 3.87%	0.76% to 1.30%
Expected term (years)	5.75 to 6.65	7.00

Summary of Stock Option Activity

Stock option activity during the years ended December 31, 2022 and 2021 is as follows:

Stock options	Number of shares	Weighted average exercise price		Weighted average remaining contractual term	Aggregate intrinsic value (in thousands)
Balance at January 1, 2022	6,921,180	$	0.88
Granted	2,940,064	4.67
Exercised	(973,389)	0.90
Forfeited	(836,505)	2.35
Expired	(1,876)	0.97
Balance at December 31, 2022	8,049,474	$	2.14	7.64	$	4,081
Vested Options Exercisable at December 31, 2022	2,860,085	$	1.34	6.90	$	2,061

Stock options	Number of shares	Weighted average exercise price		Weighted average remaining contractual term	Aggregate intrinsic value (in thousands)
Balance at January 1, 2021	8,683,952	$	0.85
Granted	1,182,218	1.08
Exercised	(2,175,986)	0.87
Forfeited	(769,004)	0.87
Expired	—	—
Balance at December 31, 2021	6,921,180	$	0.88	8.92	$	61,379
Vested Options Exercisable at December 31, 2021	1,821,909	$	0.87	7.78	$	16,185

Summary of the Activity for the RSUs and RSAs

A summary of the activity for the RSUs and RSAs for the years ended December 31, 2022 and 2021, respectively, are shown in the following tables:

	Year Ended December 31,
	2022			2021
	Number of Shares	Weighted Average Grant Date Fair Value		Number of Shares	Weighted Average Grant Date Fair Value
Unvested at beginning of year	1,291,492	$	10.98	1,390,839	10.98
Granted	2,163,135	5.74		—	—
Vested	(760,973)	9.31		—	—
Forfeited	(587,114)	7.21		(99,347)	10.98
Unvested at end of year	2,106,540	$	7.25	1,291,492	$	10.98

            A summary of the activity for the equity-classified Medical RSUs for the year ended December 31, 2022 is shown in the following table:

	Number of Shares
Balance at January 1, 2022	—
Granted	208,881
Vested	—
Forfeited	(61,411)
Balance at December 31, 2022	147,470

Schedule of Share-Based Payment Award, Earnout Shares, Valuation Assumptions

The assumptions used in the Monte-Carlo Simulation model for the Earnout Shares granted on the Closing Date are provided in the following table:

	November 12, 2021
Valuation assumptions
Expected dividend yield	—	%
Expected volatility	35.00	%
Risk-free interest rate	0.85	%

Summary of Share-Based Payment Arrangement, Outstanding Award, Activity, Excluding Option

A summary of the activity for the Employees Earnout Shares for the years ended December 31, 2022 and 2021 is shown in the following tables:

	Year Ended December 31,
	2022	2021
Outstanding at beginning of year	1,602,435	—
Granted	—	1,603,322
Forfeited	(184,803)	(887)
Outstanding at end of year	1,417,632	1,602,435